• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺泡性氧中毒与危重症 SARS-CoV-2 肺炎肺损伤加重。

Alveolar Hyperoxia and Exacerbation of Lung Injury in Critically Ill SARS-CoV-2 Pneumonia.

机构信息

NIHR Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton SO16 6YD, UK.

Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton SO16 6YD, UK.

出版信息

Med Sci (Basel). 2023 Nov 1;11(4):70. doi: 10.3390/medsci11040070.

DOI:10.3390/medsci11040070
PMID:37987325
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10660857/
Abstract

Acute hypoxic respiratory failure (AHRF) is a prominent feature of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) critical illness. The severity of gas exchange impairment correlates with worse prognosis, and AHRF requiring mechanical ventilation is associated with substantial mortality. Persistent impaired gas exchange leading to hypoxemia often warrants the prolonged administration of a high fraction of inspired oxygen (FiO). In SARS-CoV-2 AHRF, systemic vasculopathy with lung microthrombosis and microangiopathy further exacerbates poor gas exchange due to alveolar inflammation and oedema. Capillary congestion with microthrombosis is a common autopsy finding in the lungs of patients who die with coronavirus disease 2019 (COVID-19)-associated acute respiratory distress syndrome. The need for a high FiO to normalise arterial hypoxemia and tissue hypoxia can result in alveolar hyperoxia. This in turn can lead to local alveolar oxidative stress with associated inflammation, alveolar epithelial cell apoptosis, surfactant dysfunction, pulmonary vascular abnormalities, resorption atelectasis, and impairment of innate immunity predisposing to secondary bacterial infections. While oxygen is a life-saving treatment, alveolar hyperoxia may exacerbate pre-existing lung injury. In this review, we provide a summary of oxygen toxicity mechanisms, evaluating the consequences of alveolar hyperoxia in COVID-19 and propose established and potential exploratory treatment pathways to minimise alveolar hyperoxia.

摘要

急性低氧性呼吸衰竭(AHRF)是严重急性呼吸综合征冠状病毒 2 型(SARS-CoV-2)危重病的突出特征。气体交换受损的严重程度与预后较差相关,需要机械通气的 AHRF与较高的死亡率相关。持续的气体交换受损导致低氧血症,通常需要长时间给予高吸入氧分数(FiO)。在 SARS-CoV-2 型 AHRF 中,系统性血管病伴肺微血栓和微血管病进一步加重了由于肺泡炎症和水肿导致的气体交换不良。毛细血管充血伴微血栓是死于与 2019 年冠状病毒病(COVID-19)相关的急性呼吸窘迫综合征的患者肺部的常见尸检发现。为了使动脉低氧血症和组织缺氧正常化而需要高 FiO,可能导致肺泡过度氧合。这反过来又可能导致局部肺泡氧化应激,伴发炎症、肺泡上皮细胞凋亡、表面活性剂功能障碍、肺血管异常、吸收性肺不张和固有免疫受损,从而容易继发细菌感染。虽然氧气是一种救命的治疗方法,但肺泡过度氧合可能会加重先前存在的肺损伤。在这篇综述中,我们总结了氧毒性机制,评估了 COVID-19 中肺泡过度氧合的后果,并提出了既定和潜在的探索性治疗途径,以尽量减少肺泡过度氧合。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64e8/10660857/71d83070ccb2/medsci-11-00070-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64e8/10660857/03fcbc0b6366/medsci-11-00070-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64e8/10660857/22978da89bf9/medsci-11-00070-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64e8/10660857/71d83070ccb2/medsci-11-00070-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64e8/10660857/03fcbc0b6366/medsci-11-00070-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64e8/10660857/22978da89bf9/medsci-11-00070-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64e8/10660857/71d83070ccb2/medsci-11-00070-g003.jpg

相似文献

1
Alveolar Hyperoxia and Exacerbation of Lung Injury in Critically Ill SARS-CoV-2 Pneumonia.肺泡性氧中毒与危重症 SARS-CoV-2 肺炎肺损伤加重。
Med Sci (Basel). 2023 Nov 1;11(4):70. doi: 10.3390/medsci11040070.
2
Dual effects of supplemental oxygen on pulmonary infection, inflammatory lung injury, and neuromodulation in aging and COVID-19.补充氧气对衰老和 COVID-19 中的肺部感染、炎症性肺损伤和神经调节的双重影响。
Free Radic Biol Med. 2022 Sep;190:247-263. doi: 10.1016/j.freeradbiomed.2022.08.004. Epub 2022 Aug 11.
3
Hyperoxia and modulation of pulmonary vascular and immune responses in COVID-19.COVID-19 中的高氧血症和肺血管及免疫反应的调节。
Am J Physiol Lung Cell Mol Physiol. 2021 Jan 1;320(1):L12-L16. doi: 10.1152/ajplung.00304.2020. Epub 2020 Oct 14.
4
Intravenous sulforhodamine B reduces alveolar surface tension, improves oxygenation, and reduces ventilation injury in a respiratory distress model.静脉注射磺罗丹明B可降低呼吸窘迫模型中的肺泡表面张力,改善氧合,并减轻通气损伤。
J Appl Physiol (1985). 2021 May 1;130(5):1305-1316. doi: 10.1152/japplphysiol.00421.2020. Epub 2020 Nov 19.
5
Mechanical ventilation in COVID-19: A physiological perspective.新型冠状病毒肺炎的机械通气:生理视角。
Exp Physiol. 2022 Jul;107(7):683-693. doi: 10.1113/EP089400. Epub 2021 Sep 27.
6
A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial.一项评估静脉注射瑞维鲁单抗对比 COVID-19 重症肺炎、急性肺损伤或急性呼吸窘迫综合征患者最佳支持治疗的疗效和安全性的 III 期开放性标签、随机对照研究:一项随机对照试验研究方案的结构性总结。
Trials. 2020 Jul 13;21(1):639. doi: 10.1186/s13063-020-04548-z.
7
Pathophysiology of Acute Respiratory Distress Syndrome and COVID-19 Lung Injury.急性呼吸窘迫综合征和 COVID-19 肺损伤的病理生理学。
Crit Care Clin. 2021 Oct;37(4):749-776. doi: 10.1016/j.ccc.2021.05.003. Epub 2021 May 28.
8
Zilucoplan in patients with acute hypoxic respiratory failure due to COVID-19 (ZILU-COV): A structured summary of a study protocol for a randomised controlled trial.泽卢科普兰治疗 COVID-19 所致急性低氧性呼吸衰竭患者的疗效(ZILU-COV):一项随机对照试验研究方案的结构化总结。
Trials. 2020 Nov 19;21(1):934. doi: 10.1186/s13063-020-04884-0.
9
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
10
Activation of alveolar epithelial ER stress by β-coronavirus infection disrupts surfactant homeostasis in mice: implications for COVID-19 respiratory failure.β 冠状病毒感染激活肺泡上皮细胞内质网应激,破坏小鼠表面活性物质的动态平衡:对 COVID-19 呼吸衰竭的启示。
Am J Physiol Lung Cell Mol Physiol. 2024 Aug 1;327(2):L232-L249. doi: 10.1152/ajplung.00324.2023. Epub 2024 Jun 11.

引用本文的文献

1
Meta-analysis of budesonide and surfactant combination for the prevention of bronchopulmonary dysplasia in preterm neonates based on gestational age.基于胎龄的布地奈德与表面活性剂联合预防早产儿支气管肺发育不良的荟萃分析。
Front Pediatr. 2025 Apr 24;13:1518957. doi: 10.3389/fped.2025.1518957. eCollection 2025.
2
Nonlinear association between admission oxygen partial pressure and in-hospital and one-year all-cause mortality in patients with coronavirus disease pneumonia: A retrospective cohort study.新型冠状病毒肺炎患者入院时氧分压与院内及一年全因死亡率之间的非线性关联:一项回顾性队列研究
Sci Prog. 2024 Oct-Dec;107(4):368504241310737. doi: 10.1177/00368504241310737.
3

本文引用的文献

1
Protocol and statistical analysis plan for the mega randomised registry trial research program comparing conservative versus liberal oxygenation targets in adults receiving unplanned invasive mechanical ventilation in the ICU (Mega-ROX).比较重症监护病房(ICU)中接受非计划性有创机械通气的成人患者保守与宽松氧合目标的大型随机注册试验研究项目的方案和统计分析计划(Mega-ROX)
Crit Care Resusc. 2023 Oct 19;24(2):137-149. doi: 10.51893/2022.2.OA4. eCollection 2022 Jun 6.
2
Higher versus lower fractions of inspired oxygen or targets of arterial oxygenation for adults admitted to the intensive care unit.对于入住重症监护病房的成年人,较高与较低吸氧分数或动脉血氧目标。
Cochrane Database Syst Rev. 2023 Sep 13;9(9):CD012631. doi: 10.1002/14651858.CD012631.pub3.
3
COVID-19: a multi-organ perspective.
新型冠状病毒肺炎:多器官视角。
Front Cell Infect Microbiol. 2024 Oct 18;14:1425547. doi: 10.3389/fcimb.2024.1425547. eCollection 2024.
4
Hyperoxia in Sepsis and Septic Shock: A Comprehensive Review of Clinical Evidence and Therapeutic Implications.脓毒症和脓毒性休克中的高氧血症:临床证据与治疗意义的全面综述
Cureus. 2024 Sep 4;16(9):e68597. doi: 10.7759/cureus.68597. eCollection 2024 Sep.
5
Stable Nitroxide as Diagnostic Tools for Monitoring of Oxidative Stress and Hypoalbuminemia in the Context of COVID-19.稳定氮氧化物作为 COVID-19 氧化应激和低白蛋白血症监测的诊断工具。
Int J Mol Sci. 2024 Jul 24;25(15):8045. doi: 10.3390/ijms25158045.
6
Lower or higher oxygenation targets in the intensive care unit: an individual patient data meta-analysis.在重症监护病房中更低或更高的氧合目标:一项个体患者数据荟萃分析。
Intensive Care Med. 2024 Aug;50(8):1275-1286. doi: 10.1007/s00134-024-07523-3. Epub 2024 Jul 11.
7
Perioperative oxygenation-what's the stress?围手术期氧合——压力是什么?
BJA Open. 2024 Mar 20;10:100277. doi: 10.1016/j.bjao.2024.100277. eCollection 2024 Jun.
8
Impact of hyperoxia on the gut during critical illnesses.危重病期间的高氧对肠道的影响。
Crit Care. 2024 Mar 1;28(1):66. doi: 10.1186/s13054-024-04848-9.
Targeting Inflammasome Activation in Viral Infection: A Therapeutic Solution?靶向病毒感染中的炎症小体激活:一种治疗方法?
Viruses. 2023 Jun 27;15(7):1451. doi: 10.3390/v15071451.
4
Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support-Free Days in Patients Hospitalized With COVID-19: A Randomized Clinical Trial.血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂对 COVID-19 住院患者器官支持无依赖天数的影响:一项随机临床试验。
JAMA. 2023 Apr 11;329(14):1183-1196. doi: 10.1001/jama.2023.4480.
5
Oxygen-Saturation Targets for Critically Ill Adults Receiving Mechanical Ventilation.重症机械通气患者的氧饱和度目标。
N Engl J Med. 2022 Nov 10;387(19):1759-1769. doi: 10.1056/NEJMoa2208415. Epub 2022 Oct 24.
6
Intensive care physicians' perceptions of the diagnosis & management of patients with acute hypoxic respiratory failure associated with COVID-19: A UK based survey.重症监护医师对与COVID-19相关的急性低氧性呼吸衰竭患者的诊断与管理的看法:一项基于英国的调查。
J Intensive Care Soc. 2022 Aug;23(3):285-292. doi: 10.1177/17511437211002352. Epub 2021 Mar 15.
7
COVID-19 infection: an overview on cytokine storm and related interventions.COVID-19 感染:细胞因子风暴及相关干预措施概述。
Virol J. 2022 May 26;19(1):92. doi: 10.1186/s12985-022-01814-1.
8
Oxygen Targets During Mechanical Ventilation in the ICU: A Systematic Review and Meta-Analysis.重症监护病房机械通气期间的氧目标:系统评价与荟萃分析
Crit Care Explor. 2022 Mar 25;4(4):e0652. doi: 10.1097/CCE.0000000000000652. eCollection 2022 Apr.
9
Compassionate use of Pulmonary Vasodilators in Acute Severe Hypoxic Respiratory Failure due to COVID-19.COVID-19 所致急性严重低氧性呼吸衰竭患者的肺血管扩张剂同情使用。
J Intensive Care Med. 2022 Aug;37(8):1101-1111. doi: 10.1177/08850666221086521. Epub 2022 Apr 4.
10
Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial.抗血小板治疗对COVID-19重症患者生存及无器官支持天数的影响:一项随机临床试验
JAMA. 2022 Apr 5;327(13):1247-1259. doi: 10.1001/jama.2022.2910.